Hebei University Company In-licenses Cancer Molecule from Sareum of Britain

Hebei Medical University Biomedical Engineering Center (HMUBEC) in-licensed China rights to a pre-clinical cancer treatment from Sareum Holdings plc of Britain. HMUBEC is part of Hebei Medical University Science & Technology General Company (HMUSTGC), which has labs, manufacturing facilities and sales/distribution channels. Since its founding in 1992, HMUSTGC has developed more than 85 therapeutic products and medical devices for the Chinese market. More details.... Stock Symbol: (AIM: SAR) Share this with colleagues: // //